Literature DB >> 4202191

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

J W Yates, J F Holland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4202191     DOI： 10.1002/1097-0142(197312)32:6<1490::aid-cncr2820320628>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  31 in total

1.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

Authors:  J M Vossen; P J Heidt; H van den Berg; E J Gerritsen; J Hermans; L J Dooren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-01       Impact factor: 3.267

3.  Prolonged granulocytopenia due to selective antimicrobial modulation of the intestinal flora of irradiated mice: the impact on recovery from infection.

Authors:  H F Guiot; E F Tordoir-van der Bent; A V Helmig-Schurter
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

4.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. II. Organizational and statistical concept.

Authors:  W Gaus; F Wendt; G Wolf
Journal:  Infection       Date:  1977       Impact factor: 3.553

5.  E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods.

Authors: 
Journal:  Infection       Date:  1982       Impact factor: 3.553

Review 6.  Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.

Authors:  G Maschmeyer
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Infection in immunodepressed patients. The approach to diagnosis and treatment.

Authors:  E H Nauta; R van Furth
Journal:  Infection       Date:  1975       Impact factor: 3.553

8.  Isolation and rapid identification of yeasts from compromised hosts.

Authors:  G A Land; G L Dorn; W H Fleming; T A Beadles; J H Foxworth
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

Review 9.  Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?

Authors:  Lucy E Horton; Nina M Haste; Randy A Taplitz
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 3.952

10.  Iatrogenic and idiopathic acute myelogenous leukemia: a comparison of clinical features and treatment complications.

Authors:  C K Williams; J Cuttner; T Ohnuma; E P Ambinder; P P Ferreira; J F Holland
Journal:  Med Oncol Tumor Pharmacother       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.